SEC Form 4 · accession 0001126234-16-000275
NEWLINK GENETICS CORP · (NLNK)
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernest Talarico III
Director
Period of report
Jun 6, 2016
Accepted (ET)
Jun 8, 2016 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001126234
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2016 | P | 4,065 | $12.32 | A | 32,223 | D | |
| Common Stock | holding | — | — | — | 1,564 | I | By son's trust | |
| Common Stock | holding | — | — | — | 1,564 | I | By daughter's trust | |
| Common StockF2 | holding | — | — | — | 1,737 | I | - | |
| Common StockF3 | holding | — | — | — | 977 | I | - |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.31 to $12.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4.
- F2These shares are held by the spouse of the Reporting Person in a Roth IRA account.
- F3These shares are held by the Reporting Person in a Roth IRA account.